Protagonist Therapeutics Inc sell StockNews.com
Start price
30.09.23
/
50%
€78.00
Target price
30.09.24
-
Performance (%)
-
End price
01.10.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 11.429% | 11.429% | 257.798% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by StockNews_com for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€41.80
31.05.25
31.05.25
-
31.05.26
31.05.26
86.60%
27.02.26
27.02.26
Stopped prediction by StockNews_com for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€78.00
18.10.23
18.10.23
-
18.10.24
18.10.24
-
19.10.24
19.10.24